General Archive
-
Articles, News releasesLifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate…
-
News releases£1million partnership aims to develop new treatments for congenital muscular dystrophy
Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop…
-
News releasesTribune Therapeutics raises EUR 37 million for next-generation anti-fibrotic therapies
Tribune Therapeutics AB, a biotechnology company dedicated to treating the root causes of fibrotic diseases, today announced it has raised…
-
News releasesHillstar Bio closes $67 million Series A financing round
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful…
-
News releasesLifeArc invests in Maxion Therapeutics Series A
Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases,…
-
News releasesLifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALS
LifeArc has announced a collaboration with Neuropeutics Inc to develop a new small molecule for the treatment of motor neuron…
-
News releasesNew AI tool aims to detect early signs of dementia during routine eye tests
Data scientists and clinical researchers are working with high street opticians for the first time to develop a digital tool…
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
News releasesThird global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
News releasesLifeArc appoints Chief Medical Officer to deliver more scientific breakthroughs for patients
LifeArc has appointed healthcare leader and pharmaceutical industry expert, Dr Jonathan Morgan, as the charity’s first Chief Medical Officer.. Jonathan…
-
News releases£2.7m infectious disease fund to boost rapid testing, drug trials and innovative specimen storage
Rapid diagnostic tests for deadly global viral threats, repurposing antibiotics to tackle neglected tropical diseases and a potential solution to…
-
News releasesLifeArc Ventures invests in Fluid Biomed
Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an…